Matches in Nanopublications for { ?s ?p "[Inhibition of polo-like kinase 1 (Plk1) enhances the antineoplastic activity of metformin in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- assertion description "[Inhibition of polo-like kinase 1 (Plk1) enhances the antineoplastic activity of metformin in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Inhibition of polo-like kinase 1 (Plk1) enhances the antineoplastic activity of metformin in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1248108.RAmk3SJ8CAcsb5Gx2EHImUOKiwrDhu4bNgka_azaBd7zs130_assertion description "[Inhibition of polo-like kinase 1 (Plk1) enhances the antineoplastic activity of metformin in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1248108.RAmk3SJ8CAcsb5Gx2EHImUOKiwrDhu4bNgka_azaBd7zs130_provenance.
- NP1248109.RA7c92H3isXnUTEhoHpkfcTAVo4lLCMWs6NXB-UhXC934130_assertion description "[Inhibition of polo-like kinase 1 (Plk1) enhances the antineoplastic activity of metformin in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1248109.RA7c92H3isXnUTEhoHpkfcTAVo4lLCMWs6NXB-UhXC934130_provenance.